BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
468 results:

  • 1. Distinguishing egfr mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
    Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
    Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities.
    Ahirwar K; Kumar A; Srivastava N; Saraf SA; Shukla R
    Int J Biol Macromol; 2024 May; 266(Pt 1):131048. PubMed ID: 38522697
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical Management of Patients with Non-Small Cell Lung cancer, brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
    Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
    Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
    Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
    JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Signaling Pathways of AXL Receptor Tyrosine Kinase Contribute to the Pathogenetic Mechanisms of Glioblastoma.
    Repici A; Ardizzone A; De Luca F; Colarossi L; Prestifilippo A; Pizzino G; Paterniti I; Esposito E; Capra AP
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391974
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nanoplasmonic Detection of egfr Mutations Based on Extracellular Vesicle-Derived egfr-Drug Interaction.
    Han J; Jung JH; Lee SY; Park JH
    ACS Appl Mater Interfaces; 2024 Feb; 16(7):8266-8274. PubMed ID: 38335730
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrated Proteogenomics Uncover Mechanisms of Glioblastoma Evolution, Pointing to Novel Therapeutic Targets.
    Li J; Shih LK; Brat DJ
    Cancer Res; 2024 May; 84(9):1379-1381. PubMed ID: 38330148
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Artificial Intelligence Imaging for Predicting High-risk Molecular Markers of Gliomas.
    Liang Q; Jing H; Shao Y; Wang Y; Zhang H
    Clin Neuroradiol; 2024 Mar; 34(1):33-43. PubMed ID: 38277059
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma.
    Lim-Fat MJ; Iorgulescu JB; Rahman R; Bhave V; Muzikansky A; Woodward E; Whorral S; Allen M; Touat M; Li X; Xy G; Patel J; Gerstner ER; Kalpathy-Cramer J; Youssef G; Chukwueke U; McFaline-Figueroa JR; Nayak L; Lee EQ; Reardon DA; Beroukhim R; Huang RY; Bi WL; Ligon KL; Wen PY
    Clin Cancer Res; 2024 Apr; 30(7):1327-1337. PubMed ID: 38252427
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
    On J; Natsumeda M; Takahashi H; Koyama A; Shibuma S; Shibata N; Watanabe J; Saito S; Kanemaru Y; Tsukamoto Y; Okada M; Ogura R; Eda T; Tada M; Shimizu H; Adachi JI; Mishima K; Nishikawa R; Kakita A; Oishi M
    J Neurooncol; 2024 Jan; 166(2):273-282. PubMed ID: 38227143
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Analysis of Histomorphologic/Molecular Association and Immune Checkpoint Regulators in Epithelioid Glioblastoma and Pleomorphic Xanthoastrocytoma: Are These Tumors Potential Candidates for Immune Checkpoint Blockade?
    Mahajan S; Singh J; Dandapath I; Jha P; Chaturvedi S; Ahuja A; Bhardwaj M; Saran R; Garg A; Sharma MC; Manjunath N; Suri A; Sarkar C; Suri V
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):84-95. PubMed ID: 38158760
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review.
    Hong G
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138247
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Case report: Successful sequential therapy of crizotinb and entrectinib in ROS1-positive non-small-cell lung cancer with brain metastasis in later-settings.
    Dong W; Zhuge J; Yu P; Liu K; Yang M; Wang H
    Medicine (Baltimore); 2023 Dec; 102(51):e36591. PubMed ID: 38134118
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Practical approach to molecular pathology of central nervous system tumours].
    Vida L; Horváth B; Kajtár B
    Magy Onkol; 2023 Dec; 67(4):304-313. PubMed ID: 38109509
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
    Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
    Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience.
    Molica C; Gili A; Nardelli C; Pierini T; Arniani S; Beacci D; Mavridou E; Mandarano M; Corinaldesi R; Metro G; Gorello P; Giovenali P; Cenci N; Castrioto C; Lupattelli M; Roila F; Mecucci C; La Starza R
    Sci Rep; 2023 Nov; 13(1):20101. PubMed ID: 37973912
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Stroke as initial manifestation of non-small cell lung cancer with Trousseau syndrome.
    Hong W; Zhang T; Shan C; Li H; Lin T; Liu D; Zhen J; Li J; Lai M; Zhou Z; Zhou C; Zhou M; Wang M; Cai L; Wen L
    BMC Cancer; 2023 Nov; 23(1):1096. PubMed ID: 37950224
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A multi-task deep learning model for egfr genotyping prediction and GTV segmentation of brain metastasis.
    Zhou Z; Wang M; Zhao R; Shao Y; Xing L; Qiu Q; Yin Y
    J Transl Med; 2023 Nov; 21(1):788. PubMed ID: 37936137
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Glioma genetic profiles associated with electrophysiologic hyperexcitability.
    Tobochnik S; Dorotan MKC; Ghosh HS; Lapinskas E; Vogelzang J; Reardon DA; Ligon KL; Bi WL; Smirnakis SM; Lee JW
    Neuro Oncol; 2024 Feb; 26(2):323-334. PubMed ID: 37713468
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical characteristics and their influences on the survival of leptomeningeal metastasis derived from lung adenocarcinoma harboring epithelial growth factor receptor mutation].
    Jiang AF; Zhou SS; Zhou Q; Zhao J; Li XP; Zhou RR; Li B
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(34):2713-2719. PubMed ID: 37675543
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 24.